Adjunctive risperidone treatment in combat veterans with chronic PTSD [5]

Journal of Clinical Psychopharmacology

Volumn 24, Issue 5, 2004, Pages 556-559

  David, Daniella ^a,b   De Faria, Ludmila ^a,b   Lapeyra, Olga ^a,b   Mellman, Thomas A ^c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; METOPROLOL; OLANZAPINE; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

ADULT; BATTLE INJURY; CHRONIC DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONSTIPATION; DOSE TIME EFFECT RELATION; EXTRAPYRAMIDAL SYMPTOM; HEADACHE; HUMAN; LETTER; MALE; MOTOR DYSFUNCTION; NEGATIVE SYNDROME; NOSE CONGESTION; OPEN STUDY; PATHOGENESIS; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; SEDATION; SIDE EFFECT; SINUS TACHYCARDIA; SOLDIER; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; TREMOR; XEROSTOMIA;

ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; COMBAT DISORDERS; DRUG THERAPY, COMBINATION; HUMANS; MALE; MIDDLE AGED; RISPERIDONE; TREATMENT OUTCOME; VETERANS; VIETNAM;

EID: 4644312262     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000138771.46353.59     Document Type: Letter

References (14)

1. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry. 1995;52:1048-1060.
2. Kulka RA, Schlenger WE, Fairbank JA, et al. Trauma and the Vietnam War Generation. New York: Brunner/Mazel; 1990.
3. Butler RW, Mueser KT, Sprock J, et al. Positive symptoms of psychosis in posttraumatic stress disorder. Biol Psychiatry. 1996;39:839-844.
4. David D, Kutcher GS, Jackson EI, et al. Psychotic symptoms in combat-related posttraumatic stress disorder. J Clin Psychiatry. 1999;60:29-32.
5. Hamner MB, Frueh BC, Ulmer HG, et al. Psychotic features and illness severity in combat veterans with chronic posttraumatic stress disorder. Biol Psychiatry. 1999;45:846-852.
6. Davidson JRT, Rothbaum BO, van der Kolk BA, et al. Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001;58:485-492.
7. Hamner MB, Deitsch SE, Brodrick PS, et al. Quetiapine treatment in patients with post-traumatic stress disorder: an open trial of adjunctive therapy. J Clin Psychopharmacol. 2003;23:15-20.
8. Hamner MB, Faldowski RA, Ulmer HG, et al. Adjunctive risperidone treatment in post-traumatic stress disorder: a preliminary controlled trial of effects on comorbid psychotic symptoms. Int Clin Psychopharmacol. 2003;18:1-8.
9. Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry. 2002;159:1777-1779.
10. Marder SR, Meibach RC. Risperidone in the treatment of schizophrenia. Am J Psychiatry. 1994;151:825-835.
11. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33. Quiz 34-57.
12. Blake DD, Weather FW, Nagy LM, et al. A clinician rating scale for assessing current and lifetime PTSD: the CAPS-1. Behav Ther. 1990;13:187-188.
13. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
14. Morrison SD, Chaffin S, Chase TV. Aggression in adolescents: use of the Buss-Durkee Inventory. South Med J. 1975;68:431-436.